logo

Research on Integrative Medicine

  • Chinese medicine is a highly complex medical science that requires integration with Western medicine and multidisciplinary research to promote its internationalization, paving the way for Hong Kong to become a centre of excellence for integrative medicine and for the internationalization of Chinese medicine. On the research front, the School is exploring new research areas, while incorporating cutting-edge technologies, such as big data analysis and AI, into its studies.

Current Research on Integrative Medicine

  • Professor Yi Bin FENG

    Project Period: 2023-06-01 to 2025-01-31

    Examining the immunomodulatory and health improving function of a Chinese medicine nutritional supplement Cs4 on immunity-related disorders in the post-COVID era


    Project Period: 2021-02-01 to 2024-12-31

    Based on the theory of ‘body constitution of Chinese Medicine’ and ‘combination of prescription and syndrome’ to improve COVID-19 susceptible body constitution of residents in Hong Kong


    Project Period: 2021-09-01 to 2023-08-31

    Elucidation of the reversal effect of baicalin on hepatocellular carcinoma-associated cachexia


    More Details

  • Professor Jian Gang SHEN

    Project Period: 2019-2025

    Artificial intelligence recognitions for traditional Chinese medicine pulse patterns and its correlation study with body consititution in healthy human subjects. Health and Medical Research Fund, Hong Kong No. 1718811. 2019-2025.


    Project Period: 2017-2025

    Chemical Biology Approach to Molecular Medicine. Areas of Excellence Scheme 2016/17, Research Grants Council AoE/P-705/16. 2017-2025


    Project Period: 2023-2025

    Elucidating neuroprotective effects of Angong Niuhuang Pill on regulating gut microbiota in ischemic stroke. Beijing Tong Reng Tang Pharmaceutical Inc. LTD Contract Research Project. 2023-2025.


    More Details

  • Professor Zhang Jin ZHANG

    Project Period: 1 January 2022 – 31 December 2024

    Transcutaneous electrical acupoint stimulation and dense cranial electroacupuncture stimulation for psychiatric sequelae and related biomarkers in women victims of domestic violence: a randomized controlled trial.


    Project Period: 1 September 2020 – 31 August 2024

    Combining acupuncture and acupressure for community-dwelling elderly with dementia: an assessor-blinded, randomized controlled trial


    Project Period: July 1, 2024 – June 30, 2024

    The validation and beneficial effects of Yizhi Baduanjin (益智八段錦) for patients with Mild Cognitive Impairment: a pilot randomised controlled trial


    Project Period: September 1, 2024 – August 31, 2027

    Dense cranial electroacupuncture stimulation plus body acupuncture for adolescents with emotional disorders: a randomized controlled trial with observations on salivary oxytocin and cortisol changes


    Project Period: September 1, 2024 – August 31, 2025

    Efficacy of health products combining traditional Chinese medicines, vitamins and amino acids for emotional disorders and insomnia: a pilot double-blinded, randomized placebo-controlled trial


    More Details

  • Professor Hai Yong CHEN

    Project Period: 1 April 2024-30 Jun 2025

    Development of an expert consensus on clinical practice of Chinese medicine for the prevention of seasonal influenza in Hong Kong elderly via the Delphi method


    Project Period: 1 April 2023-31 March 2025

    Clinical effectiveness Study for integrated Chinese-Western Medicine (WCWM) programme for the Hospital Authority


    More Details

  • Professor Xiang LIN

    Project Period: 15 April 2024-14 April 2026

    The Therapeutic Potential of Immunomodulatory Compounds from Astragali Radix on Primary Sjogren’s Syndrome


    Project Period: 1 September 2023- 31 August 2025

    Calycosin ameliorates experimental Sjogren’s syndrome via inhibiting effector T cell response


    More Details

  • Professor Ning WANG

    Project Period: 1 January 2025- 31 December 2028

    Berberine potentiates anti-PD-1 efficacy in human hepatocellular carcinoma


    Project Period: 1 November 2024 – 31 October 2027

    Batatasin I, an active component from tonic Chinese medicine Dioscoreae Rhizoma, mitigates inflammation-related muscle and adipose wasting in pancreatic cancer-associated cachexia


    Project Period: 1 February 2023 – 31 January 2025

    The Study of CP1-CHM Regulating Lipid Metabolism in Obese Patients through Gut Microbiome


    Project Period: 1 December 2021 – 30 November 2024

    Investigation of the effect of berberine to overcome sorafenib resistance in human hepatocellular carcinoma via suppressing Warburg effect


    Project Period: 1 April 2018 – 31 March 2025

    Investigation on the effect of berberine on improvement of diabetic retinopathy in insulin-treated diabetic mellitus


    Project Period: 1 January 2014 – 31 December 2016

    Berberine suppresses nascent protein synthesis in hepatocellular carcinoma


    More Details